(CUE) Cue Biopharma complete technical analysis [charts+indicators] | Buy/Sell Cue Biopharma | (CUE) share price targets
Complete technical analysis of Cue Biopharma (CUE) by charts plus indicators, forecast predictions and share price targets for Cue Biopharma (CUE)
Cue Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-02 View latest technical analysis
10 day averaged volume of Cue Biopharma is 924590
| Date | Daily Closing Price | Open | High | Low | Volume |
| 02 Fri Aug 2024 | 0.73 | 0.78 | 0.82 | 0.73 | 0.22 times |
| 01 Thu Aug 2024 | 0.78 | 0.83 | 0.87 | 0.76 | 0.357 times |
| 31 Wed Jul 2024 | 0.84 | 0.75 | 0.92 | 0.73 | 1.15 times |
| 30 Tue Jul 2024 | 0.77 | 0.67 | 0.93 | 0.65 | 6.14 times |
| 29 Mon Jul 2024 | 0.65 | 0.67 | 0.68 | 0.62 | 0.411 times |
| 26 Fri Jul 2024 | 0.67 | 0.70 | 0.73 | 0.67 | 0.456 times |
| 25 Thu Jul 2024 | 0.70 | 0.72 | 0.75 | 0.68 | 0.212 times |
| 24 Wed Jul 2024 | 0.70 | 0.74 | 0.76 | 0.69 | 0.285 times |
| 23 Tue Jul 2024 | 0.74 | 0.78 | 0.80 | 0.74 | 0.252 times |
| 22 Mon Jul 2024 | 0.77 | 0.76 | 0.81 | 0.75 | 0.201 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 0.7 as stoploss in an intra day buy trade for a target of 0.82. However, stock will show a bearish move below 0.7.
Share price targets for Cue Biopharma (CUE)
| Target Type | Value |
| Downside Target | 0.62 |
| Downside Target | 0.67 |
| Downside Target | 0.73 |
| Upside Target | 0.81 |
| Upside Target | 0.85 |
| Upside Target | 0.87 |
| Upside Target | 0.93 |
| Upside Target | 0.96 |
| Upside Target | 1.00 |
| Upside Target | 1.02 |
| Upside Target | 1.09 |
| Upside Target | 1.24 |
| Upside Target | 1.29 |
| Upside Target | 1.52 |
| Upside Target | 1.79 |
| Upside Target | 2.08 |
| Upside Target | 2.26 |
Intraday share price targets for Cue Biopharma (CUE)
| Target Type | Value |
| Downside Intraday Target | 0.59 |
| Downside Intraday Target | 0.45 |
| Upside Intraday Target | 0.9 |
| Upside Intraday Target | 1.07 |
| Upside Intraday Target | 0.76 |
Weekly technical analysis of Cue Biopharma (CUE)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 02 Fri Aug 2024 | 0.73 | 0.67 | 0.93 | 0.62 | 5.884 times |
| 26 Fri Jul 2024 | 0.67 | 0.76 | 0.81 | 0.67 | 0.742 times |
| 19 Fri Jul 2024 | 0.76 | 0.96 | 1.00 | 0.73 | 0.822 times |
| 12 Fri Jul 2024 | 0.94 | 0.98 | 1.02 | 0.85 | 3.976 times |
| 05 Fri Jul 2024 | 0.96 | 1.08 | 1.09 | 0.96 | 0.226 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Cue Biopharma (CUE)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 02 Fri Aug 2024 | 0.73 | 0.83 | 0.87 | 0.73 | 0.035 times |
| 31 Wed Jul 2024 | 0.84 | 1.26 | 1.29 | 0.62 | 1.611 times |
| 28 Fri Jun 2024 | 1.24 | 1.70 | 1.79 | 1.24 | 1.579 times |
| 31 Fri May 2024 | 1.63 | 1.92 | 2.26 | 1.52 | 0.871 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Cue Biopharma (CUE)
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Cue Biopharma ( (CUE) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Cue Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Cue Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Cue Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Cue Biopharma in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Cue Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.76 and Cue Biopharma (CUE) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Cue Biopharma (CUE) stock. Volume based technical analysis of Cue Biopharma (CUE) stock is negative.
Cue Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Cue Biopharma ( (CUE) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Cue Biopharma ( (CUE) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Cue Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Cue Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Cue Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Cue Biopharma in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Cue Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.76 and Cue Biopharma (CUE) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Cue Biopharma (CUE) stock. Volume based technical analysis of Cue Biopharma (CUE) stock is negative.
Cue Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.